Business Context and Reporting Period
This Form 8-K Current Report from Open Text Corporation covers events occurring on December 2, 2010, specifically the results of the Company's Annual and Special Meeting of Shareholders. The filing details the approval of corporate governance matters, including the election of directors, auditor re-appointment, and amendments to the Shareholders Rights Plan and By-laws.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder actions. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the Company's most recent Form 10-K or 10-Q for financial statements.
Material Changes and Corporate Actions
- Shareholders Rights Plan: Shareholders approved the continuation, amendment, and restatement of the Shareholders Rights Plan (Poison Pill). The plan triggers if a person acquires 20% or more of common shares, allowing other shareholders to purchase additional shares at half the market price. The plan was extended to expire at the 2013 annual meeting unless ratified for continuation until 2016.
- By-laws Amendment: Shareholders approved amendments to the By-laws to clarify officer powers, indemnification provisions, share transfer registration, quorum requirements, and electronic notice definitions. Management stated these changes are not material to substantive shareholder rights.
- Director Elections: All nine nominees for the Board of Directors were elected.
- Auditor Approval: KPMG LLP was re-appointed as the independent auditor.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary risk context provided relates to the Shareholders Rights Plan, which is designed to ensure the Board has time to assess alternatives in the event of a takeover bid, thereby lessening pressure on shareholders to tender immediately.
Key Facts for Investor Verification
- Takeover Defense Status: Verify the specific terms of the Amended Rights Plan (Exhibit 4.1) regarding the 20% trigger threshold and the 2013/2016 expiration timeline.
- Board Composition: Confirm the tenure and independence of the newly elected directors, noting that Stephen J. Sadler received the highest number of "Votes Withheld" (3,237,795) among the nominees.
- Shareholder Dissent: Note that Proposal 3 (Rights Plan) received 1,505,649 votes against, indicating a measurable level of shareholder opposition to the poison pill extension.
- Financial Data Source: As this 8-K contains no financial results, verify the most recent quarterly or annual earnings report for current financial health.